Aastrom
Biosciences is a late-stage development company
focused on human cell-based therapies. Aastrom intends
to leverage its proprietary ex vivo cell production
technology to produce patient-specific cells for
stem cell tissue repair and regeneration, and for
the treatment of cancer and other infectious diseases.
Aastrom's business is based on its proprietary AastromReplicell™
System, a patented, integrated system of instrumentation
and single-use consumable kits for the commercial
production of human cells.